Treat U is a biotechnology brand dedicated to improving patients' health by enhancing therapeutic efficacy and reducing adverse side effects, ultimately reducing treatment costs for healthcare systems. With a focus on targeted nanotechnology-based platforms for drug delivery, Treat U aims to provide effective and safe therapeutics for cancer treatment. Their innovative product, PEGASEMP™, has received Orphan Drug Designation for the treatment of malignant mesothelioma.

This groundbreaking treatment inhibits tumor growth and prevents metastization, while boasting a low incidence of side effects. Founded in January 2010 as a spin-off from the University of Coimbra, Treat U is backed by a team of entrepreneurs and scientists with extensive experience in the fields of Biotechnology and Pharmaceutical Technology. Their mission is to revolutionize treatment options, offering hope and improving the lives of patients.

For more information, visit their website or reach out to them via email